Organ Transplantation Research Today is a free monthly online journal that collates and summarizes the latest research about Organ Transplantation, including details on risks, prognosis, procedure, surgery.

Volume 4 (2007), Issue 6 (June)

1. A novel way of liver preservation improves rat liver viability upon reperfusion.
   J Zhejiang Univ Sci B, 8(5): 289-95. [Abstract] [Full-text]
2. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
   Am Heart J, 153(6): 932-40. [Abstract] [Full-text]
3. Exercise capacity and physical fitness in pediatric dialysis and kidney transplant patients.
   Pediatr Nephrol, 22(7): 1030-9. [Abstract] [Full-text]
4. The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection.
   Pediatr Nephrol, 22(7): 911-4. [Abstract] [Full-text]
5. Evaluation of clinical status, renal function, and hematopoietic variables after unilateral nephrectomy in canine kidney donors.
   J Am Vet Med Assoc, 230(11): 1653-6. [Abstract] [Full-text]
6. Is hepatic transplantation justified for primary liver cancer?
   J Surg Oncol, 95(8): 674-9. [Abstract] [Full-text]
7. Comparison of the CEDIA and MEIA assays for the measurement of sirolimus in organ transplant recipients.
   Clin Biochem, 40(9): 680-7. [Abstract] [Full-text]
8. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients.
   J Clin Microbiol, 45(6): 1759-65. [Abstract] [Full-text]
9. Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis.
   J Clin Microbiol, 45(6): 1804-10. [Abstract] [Full-text]
10. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.
    Clin Infect Dis, 45(1): 60-7. [Abstract] [Full-text]
11. Malignancy after kidney transplantation: still a challenge.
    Kidney Int, 71(12): 1197-9. [Abstract] [Full-text]
12. Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression.
    Kidney Int, 71(12): 1296-301. [Abstract] [Full-text]
13. Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender.
    Kidney Int, 71(12): 1302-9. [Abstract] [Full-text]
14. The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich.
    Kidney Int, 71(12): 1271-8. [Abstract] [Full-text]
15. The role of osteobiologics in spinal deformity.
    Neurosurg Clin N Am, 18(2): 393-401. [Abstract] [Full-text]
16. Tape-guided living donor left hepatectomy.
    Am J Surg, 194(1): 107-9. [Abstract] [Full-text]
17. Arthroscopic autologous bone graft with arthroscopic Bankart repair for a large bony defect lesion caused by recurrent shoulder dislocation.
    Arthroscopy, 23(6): 677.e1-4. [Abstract] [Full-text]
18. Improving consent rates for organ donation: the effect of an inhouse coordinator program.
    J Trauma, 62(6): 1411-4; discussion 1414-5. [Abstract] [Full-text]
19. Sirolimus and liver transplantation: clinical implications for hepatocellular carcinoma.
    Expert Opin Pharmacother, 8(9): 1275-82. [Abstract] [Full-text]
20. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years.
    Arch Intern Med, 167(11): 1183-8. [Abstract] [Full-text]
21. Posttransplant metabolic acidosis: a neglected factor in renal transplantation?
    Curr Opin Nephrol Hypertens, 16(4): 379-87. [Abstract] [Full-text]
22. Liver transplant using donors after unexpected cardiac death: novel preservation protocol and acceptance criteria.
    Am J Transplant, 7(7): 1849-55. [Abstract] [Full-text]
23. Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation.
    Am J Transplant, 7(7): 1832-42. [Abstract] [Full-text]
24. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation.
    Am J Transplant, 7(7): 1770-7. [Abstract] [Full-text]
25. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause.
    Am J Transplant, 7(7): 1743-52. [Abstract] [Full-text]
26. Reperfusion of the liver allograft with blue blood: is it still the royal perfusate?
    Am J Transplant, 7(7): 1689-91. [Abstract] [Full-text]
27. Sticky platelet syndrome: an underrecognized cause of graft dysfunction and thromboembolic complications in renal transplant recipients.
    Am J Transplant, 7(7): 1865-8. [Abstract] [Full-text]
28. Simultaneous liver-kidney transplantation: evaluation to decision making.
    Am J Transplant, 7(7): 1702-9. [Abstract] [Full-text]
29. Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients.
    Am J Transplant, 7(7): 1822-31. [Abstract] [Full-text]
30. A semi-centennial report on the participants depicted in Joel Babb's portrait, 'the first successful kidney transplantation'.
    Am J Transplant, 7(7): 1683-8. [Abstract] [Full-text]
31. Graft selection algorithm based on congestion volume for adult living donor liver transplantation.
    Am J Transplant, 7(7): 1788-96. [Abstract] [Full-text]
32. Lung transplant metalloproteinase levels are elevated prior to bronchiolitis obliterans syndrome.
    Am J Transplant, 7(7): 1856-61. [Abstract] [Full-text]
33. Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation.
    Am J Transplant, 7(7): 1797-807. [Abstract] [Full-text]
34. Genitourinary tuberculosis after renal transplantation-a report of three cases with a good clinical outcome.
    Am J Transplant, 7(7): 1862-4. [Abstract] [Full-text]
35. Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction.
    Am J Transplant, 7(7): 1808-14. [Abstract] [Full-text]
36. A comparison of long-term survivals of simultaneous pancreas-kidney transplant between African American and Caucasian recipients with basiliximab induction therapy.
    Am J Transplant, 7(7): 1815-21. [Abstract] [Full-text]
37. The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection.
    Am J Transplant, 7(7): 1842-8. [Abstract] [Full-text]
38. Retroversus implantation of a liver graft: a novel approach to the deceased donor with situs inversus totalis.
    Am J Transplant, 7(7): 1869-71. [Abstract] [Full-text]
39. Prophylactic bisphosphonate treatment prevents bone fractures after liver transplantation.
    Am J Transplant, 7(7): 1763-9. [Abstract] [Full-text]
40. Checklist: passport, plane ticket, organ transplant.
    Am J Transplant, 7(7): 1698-701. [Abstract] [Full-text]
41. Pedicled vascularized rib transfer for reconstruction of clavicle nonunions with bony defects: anatomical and biomechanical considerations.
    Plast Reconstr Surg, 120(1): 173-80. [Abstract] [Full-text]
42. Anesthesia for laparoscopic donor nephrectomy: is nitrous oxide contraindicated?
    J Urol, 178(1): 225-7; discussion 227. [Abstract] [Full-text]
43. Kidney transplantation in children with augmentation cystoplasty.
    J Urol, 178(1): 274-7; discussion 277. [Abstract] [Full-text]
44. Renal transplant in methylmalonic acidemia: could it be the best option? Report on a case at 10 years and review of the literature.
    Pediatr Nephrol, 22(8): 1209-14. [Abstract] [Full-text]
45. Technical note: medial approach for proximal tibia bone graft using a manual trephine.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104(1): e11-7. [Abstract] [Full-text]
46. Value of CT and Doppler sonography in the evaluation of hepatic vein stenosis after dual-graft living donor liver transplantation.
    AJR Am J Roentgenol, 189(1): 101-8. [Abstract] [Full-text]
47. Assessing emerging technologies--the case of organ replacement technologies: volume, durability, cost.
    Int J Technol Assess Health Care, 23(3): 331-6. [Abstract] [Full-text]
48. Evaluating the accuracy of functional biomarkers for detecting histological changes in chronic allograft nephropathy.
    Transpl Int, 20(7): 608-15. [Abstract] [Full-text]
49. Possible therapeutic effect of lipid supplementation on neurological complications in liver transplant recipients.
    Transpl Int, 20(7): 632-5. [Abstract] [Full-text]
50. Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation.
    Transpl Int, 20(7): 583-90. [Abstract] [Full-text]
51. Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
    Transpl Int, 20(7): 576-82. [Abstract] [Full-text]
52. Renal dysfunction in liver transplant patients: comparing patients transplanted for liver tumor or acute or chronic disease.
    Transpl Int, 20(7): 591-9. [Abstract] [Full-text]
53. Effects of a new immunosuppressive agent, beta-SQAG9, in swine kidney transplantation.
    Transpl Immunol, 18(1): 67-71. [Abstract] [Full-text]
54. Enhanced cardiac allograft survival by Vav1-Rac signaling blockade in a mouse model.
    Transpl Immunol, 18(1): 53-61. [Abstract] [Full-text]
55. Organ transplantation in rodents: novel applications of long-established methods.
    Transpl Immunol, 18(1): 44-52. [Abstract] [Full-text]
56. Impaired hepatic regeneration by ischemic preconditioning in a rat model of small-for-size liver transplantation.
    Transpl Immunol, 18(1): 37-43. [Abstract] [Full-text]
57. Association of Fc gamma receptor IIIB polymorphism with renal-allogrft in Chinese.
    Transpl Immunol, 18(1): 28-31. [Abstract] [Full-text]
58. Soluble CD30 in patients with antibody-mediated rejection of the kidney allograft.
    Transpl Immunol, 18(1): 22-7. [Abstract] [Full-text]
59. Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation.
    Transpl Immunol, 18(1): 13-21. [Abstract] [Full-text]
60. Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform.
    Transpl Immunol, 18(1): 7-12. [Abstract] [Full-text]
61. Prior cardiac surgery is not a contraindication for lung donor.
    Ann Thorac Surg, 84(1): 314-6. [Abstract] [Full-text]
62. N-acetylcysteine attenuates lung ischemia-reperfusion injury after lung transplantation.
    Ann Thorac Surg, 84(1): 240-6; discussion 246. [Abstract] [Full-text]
63. Treatment of hepatitis C in potential lung transplant candidates.
    Transplantation, 83(12): 1652-5. [Abstract] [Full-text]
64. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
    Transplantation, 83(12): 1648-51. [Abstract] [Full-text]
65. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
    Transplantation, 83(12): 1639-42. [Abstract] [Full-text]
66. FoxP3 mRNA transcripts and regulatory cells in renal transplant recipients 10 years after donor marrow infusion.
    Transplantation, 83(12): 1611-9. [Abstract] [Full-text]
67. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts.
    Transplantation, 83(12): 1602-10. [Abstract] [Full-text]
68. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.
    Transplantation, 83(12): 1595-601. [Abstract] [Full-text]
69. Metabolic syndrome and atherosclerotic events in renal transplant recipients.
    Transplantation, 83(12): 1577-81. [Abstract] [Full-text]
70. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
    Transplantation, 83(12): 1571-6. [Abstract] [Full-text]
71. Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy.
    Transplantation, 83(12): 1563-70. [Abstract] [Full-text]
72. Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period.
    Transplantation, 83(12): 1557-62. [Abstract] [Full-text]
73. Dual kidney transplantation: a case-control comparison with single kidney transplantation from standard and expanded criteria donors.
    Transplantation, 83(12): 1551-6. [Abstract] [Full-text]
74. Acute rejection of experimental lung allografts: characterization of intravascular mononuclear leukocytes.
    Clin Immunol, 124(1): 98-108. [Abstract] [Full-text]
75. Successful reuse of a transplanted kidney: 3-year follow-up.
    Am J Kidney Dis, 50(1): 143-5. [Abstract] [Full-text]
76. ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial.
    Am J Kidney Dis, 50(1): 133-42. [Abstract] [Full-text]
77. End-stage renal disease due to polyomavirus in a cardiac transplant patient.
    Nat Clin Pract Nephrol, 3(7): 393-6. [Abstract] [Full-text]
78. A reinforced sternal wiring technique for transverse thoracosternotomy closure in bilateral lung transplantation: from biomechanical test to clinical application.
    J Thorac Cardiovasc Surg, 134(1): 218-24. [Abstract] [Full-text]
79. The subepicardial microcirculation in heterotopically transplanted mouse hearts: an intravital multifluorescence microscopy study.
    J Thorac Cardiovasc Surg, 134(1): 210-7, 217.e1. [Abstract] [Full-text]
80. Sources of graft restriction after single lung transplantation for emphysema.
    J Thorac Cardiovasc Surg, 134(1): 204-9. [Abstract] [Full-text]

© 2004-2011 Organ Transplantation Research Today. All Rights Reserved.